Ma, X., Ding, L., Li, S., Fan, Y., Wang, X., Han, Y., . . . Liu, M. Druggable genome-wide Mendelian randomization identifies therapeutic targets for metabolic dysfunction-associated steatotic liver disease. BMC.
Chicago Style (17th ed.) CitationMa, Xiaohui, et al. Druggable Genome-wide Mendelian Randomization Identifies Therapeutic Targets for Metabolic Dysfunction-associated Steatotic Liver Disease. BMC.
MLA (9th ed.) CitationMa, Xiaohui, et al. Druggable Genome-wide Mendelian Randomization Identifies Therapeutic Targets for Metabolic Dysfunction-associated Steatotic Liver Disease. BMC.
Warning: These citations may not always be 100% accurate.